Summit Therapeutics (SMMT)
14.43
-0.34 (2.30%)
Upcoming Events
Latest Headlines
Form 4 Summit Therapeutics Inc. For: Jun 04 Filed by: DUGGAN ROBERT W
June 4, 2026 6:08 PM - SEC Filing
Form 4 Summit Therapeutics Inc. For: Jun 04 Filed by: Zanganeh Mahkam
June 4, 2026 5:45 PM - SEC Filing
Form 4 Summit Therapeutics Inc. For: Jun 04 Filed by: Soni Manmeet Singh
June 4, 2026 4:41 PM - SEC Filing
Summit Therapeutics to Participate in the 47th Annual Goldman Sachs Global Healthcare Conference
June 4, 2026 4:30 PM - BizWire
Form 8-K Summit Therapeutics Inc. For: Jun 02
June 3, 2026 8:01 AM - SEC Filing
Summit Therapeutics (SMMT) Reiterated at Overweight by Cantor Fitzgerald
June 3, 2026 6:51 AM - StreetInsider
Bernstein SocGen Reiterates Underperform Rating on Summit Therapeutics plc (SMMT)
June 1, 2026 8:23 AM - StreetInsider
Summit Therapeutics (SMMT) Reiterated at Overweight by Cantor Fitzgerald
June 1, 2026 7:55 AM - StreetInsider
Summit Therapeutics (SMMT) Reiterated at Buy by Stifel on HARMONi-6 'Win'
June 1, 2026 7:41 AM - StreetInsider
Form 8-K Summit Therapeutics Inc. For: May 30
June 1, 2026 6:57 AM - SEC Filing
Summit's ivonescimab shows survival benefit in lung cancer trial
June 1, 2026 2:53 AM - StreetInsider
Ivonescimab with Chemotherapy Demonstrated a Statistically Significant Overall Survival Benefit Compared to Tislelizumab Plus Chemotherapy in 1L Treatment of Patients with Squamous NSCLC in the HARMON
May 31, 2026 9:06 AM - BizWire
Encouraging Global Phase II Ivonescimab Data in First-Line Metastatic Colorectal Cancer Presented at ASCO 2026
May 30, 2026 8:00 AM - BizWire
Bernstein SocGen Reiterates Underperform Rating on Summit Therapeutics plc (SMMT)
May 26, 2026 9:14 AM - StreetInsider
Summit Therapeutics (SMMT) Reiterated at Overweight by Cantor Fitzgerald
May 22, 2026 7:28 AM - StreetInsider
H.C. Wainwright Downgrades Summit Therapeutics plc (SMMT) to Neutral
May 22, 2026 6:14 AM - StreetInsider
Citi Opens Cat Call on Summit Therapeutics plc (SMMT)
May 22, 2026 5:02 AM - StreetInsider
Bernstein SocGen Group Starts Summit Therapeutics plc (SMMT) at Underperform
May 21, 2026 4:23 PM - StreetInsider
A Cancer Antigen Long Thought Untouchable Is Suddenly the Hottest Target in Oncology
May 14, 2026 9:15 AM - StreetInsider
Summit Therapeutics plc (SMMT) PT Lowered to $23 at H.C. Wainwright
May 4, 2026 7:28 AM - StreetInsider
Summit Therapeutics plc (SMMT) PT Lowered to $16 at Piper Sandler
May 1, 2026 7:38 AM - StreetInsider
Form 10-Q Summit Therapeutics Inc. For: Mar 31
April 30, 2026 5:01 PM - SEC Filing
Summit Therapeutics (SMMT) Tops Q1 EPS by 4c
April 30, 2026 4:56 PM - StreetInsider
Form 8-K Summit Therapeutics Inc. For: Apr 30
April 30, 2026 4:41 PM - SEC Filing
Summit Therapeutics Reports Financial Results and Operational Progress for the First Quarter Ended March 31, 2026
April 30, 2026 4:32 PM - BizWire
Stifel on Summit Therapeutics plc (SMMT): 'first look, ever, at an emerging OS from an invonescimab P3 randomized against antiPD-1 (tislelizumab)'
April 21, 2026 12:33 PM - StreetInsider
Form DEFA14A Summit Therapeutics Inc.
April 17, 2026 5:00 PM - SEC Filing
Form ARS Summit Therapeutics Inc. For: Dec 31
April 17, 2026 4:16 PM - SEC Filing
Form DEF 14A Summit Therapeutics Inc. For: Apr 17
April 17, 2026 4:13 PM - SEC Filing
UBS Reiterates Buy Rating on Summit Therapeutics plc (SMMT)
April 17, 2026 9:58 AM - StreetInsider
Summit Therapeutics (SMMT) spreader of 2K contracts of June 25 and 30 calls, share price up 13.6%
April 16, 2026 3:26 PM - StreetInsider
Stifel Starts Summit Therapeutics plc (SMMT) at Buy, $45 PT
April 7, 2026 4:08 PM - StreetInsider
Form PRE 14A Summit Therapeutics Inc. For: Apr 06
April 6, 2026 4:29 PM - SEC Filing
Summit Therapeutics (SMMT) Reiterated at Overweight by Cantor Fitzgerald
April 6, 2026 7:40 AM - StreetInsider
Summit Therapeutics to present ivonescimab data at ELCC 2026
March 27, 2026 8:16 AM - StreetInsider
Multiple Ivonescimab Data Sets from Phase III Studies in Advanced NSCLC Patient Populations to be Featured at ELCC 2026
March 27, 2026 8:15 AM - BizWire
Summit Therapeutics (SMMT) Added to Citi 90-Day Upside Catalyst Call List
March 23, 2026 4:53 AM - StreetInsider
Jefferies Downgrades Summit Therapeutics plc (SMMT) to Hold
March 16, 2026 12:50 AM - StreetInsider
Full Article List
